跳至主要内容
临床试验/NCT03371888
NCT03371888已完成2 期

The Platelet -Rich Plasma in the Therapy of Temporomandibular Disorders

Medical University of Silesia2 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2017年12月7日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
58
试验地点
2
主要终点
Pain intensity reduction in VAS scale,(VAS scale 0-10 points)

研究概览

简要总结

The Platelet-Rich Plasma intramuscular injections into the masseter and temporalis muscle were performed to reduce painful temporomandibular disorder symptoms,such as myalgia, myofascial pain and myofascial pain with referrals. Patients(n=120) were randomly divided into two groups: experimental(n=60) and control group(n=60). In controls injections with 0,9% NaCl were performed. Pain intensity was measured with NPRS (numeriic pain rating scale, 0= no pain, 11= the worst pain that one can imagine) before(0 day), during(10 day) and after(20 day) the therapy with PRP injections.

详细描述

Patients(n=120) attending The Department of Temporomandibular Disorders and Orthodontics at the Silesian Medical University Poland, Zabrze were enrolled to the study and randomly divided into one of two groups: experimental and control group. Platelet-Rich Plasma(PRP) was prepared for each patient and an intramuscular injections of 0,5 ml PRP into 6 points at each side were performed in experimental group. A follow-up appointment was made after 10 and 20 days and in each visit an injection of PRP or 0,9% NaCl was performed. Pain intensity was measured in NPRS(numeric pain rating scale) and collected data data were analyzed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

盲法说明

double blinded study

入排标准

年龄范围
23 Years 至 42 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • presence of local myalgia, myofascial pain and myofascial pain with referral within masseter muscles according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) (II.1.A. 1, 2 and 3)
  • patient's agreement for taking part into the research study

排除标准

  • patients being treated with or addicted to analgesic drugs and/or drugs that affect muscle function
  • presence of contraindications for injection therapy
  • patients being treated by neurologist for neurological disorders and/or neuropathic pain and/or headache
  • patients after traumas to the head and neck region in the previous 2 years
  • edentulous patients
  • patients after radiotherapy
  • presence of severe mental disorders
  • pregnancy or lactation
  • pain of dental origin
  • presence of malignancy
  • drug and/or alcohol addiction
  • patients with needle phobia

研究组 & 干预措施

PRP injections

Experimental

Intramuscular injection of Platelet-Rich Plasma into the masseter and temporalis muscle

干预措施: Platelet-Rich Plasma intramuscular injections (Biological)

0,9% NaCl injections

Placebo Comparator

Intramuscular injection of 0,9% NaCl into the masseter and temporalis muscle

干预措施: Placebo Comparator: 0,9% NaCl intramuscular injections (Biological)

结局指标

主要结局

Pain intensity reduction in VAS scale,(VAS scale 0-10 points)

时间窗: 14 days

Decrease in pain intensity in masseter and temporalis muscles.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Aleksandra Nitecka-Buchta

DMD, PhD

Medical University of Silesia

研究点 (2)

Loading locations...

相似试验